Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Vical Shares Plunge as Drugmaker Says Cancer Study Missed Target
Vical Shares Plunge as Drugmaker Says Cancer Study Missed Target
Vical Shares Plunge as Drugmaker Says Cancer Study Missed Target
Submitted by
admin
on August 12, 2013 - 9:23am
Source:
Bloomberg
News Tags:
Vical
Allovectin
metastatic melanoma
Headline:
Vical Shares Plunge as Drugmaker Says Cancer Study Missed Target
Do Not Allow Advertisers to Use My Personal information
